These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 6869857
21. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times. Dercksen SJ, Linssen GH. Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138 [Abstract] [Full Text] [Related]
22. [Heparin management by activated coagulation time during cardiopulmonary bypass]. Shikano K, Shinpo H, Nasu M, Morimoto T, Suzuki T, Yada I, Kusagawa M. Kyobu Geka; 1981; 34(12):934-7. PubMed ID: 7349352 [No Abstract] [Full Text] [Related]
23. Monitoring of blood coagulation in open heart surgery. I. Effects of conventional dosages of heparin and protamine. Dercksen SJ, Linssen GH. Acta Anaesthesiol Belg; 1980; 31(2):113-9. PubMed ID: 7468137 [Abstract] [Full Text] [Related]
24. Changing systems for measuring activated clotting times: impact on the clinical practice of heparin anticoagulation during cardiac surgery. Patteril M, Stafford-Smith M, Toffaletti JG, Bute BP, Milano CA, Welsby IJ. Clin Chim Acta; 2005 Jun; 356(1-2):218-24. PubMed ID: 15936321 [Abstract] [Full Text] [Related]
25. Changes of antithrombin III and antithrombin III-heparin complex levels, and ACT in cardiac surgery. Inada E, Iwahashi K, Aoki K, Takanashi S, Kohama M, Aoki Y. Can J Anaesth; 1990 May; 37(4 Pt 2):S75. PubMed ID: 2361314 [No Abstract] [Full Text] [Related]
26. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass. Slight RD, Buell R, Nzewi OC, McClelland DB, Mankad PS. J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330 [Abstract] [Full Text] [Related]
28. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization. Okita Y, Takamoto S, Ando M, Morota T, Yamaki F, Matsukawa R, Kawashima Y. Circulation; 1997 Nov 04; 96(9 Suppl):II-376-81. PubMed ID: 9386127 [Abstract] [Full Text] [Related]
31. The relationship between heparin level and activated clotting time in the adult cardiac surgery population. Fitzgerald DJ, Patel A, Body SC, Garvin S. Perfusion; 2009 Mar 04; 24(2):93-6. PubMed ID: 19654150 [Abstract] [Full Text] [Related]
34. A comparison between arterial- and venous-sampled activated clotting time measurements. Zisman E, Rozenberg B, Katz Y, Ziser A. Isr J Med Sci; 1997 Dec 04; 33(12):786-8. PubMed ID: 9464347 [Abstract] [Full Text] [Related]
36. High molecular weight kininogen deficiency: a patient who underwent cardiac surgery. Davidson SJ, Burman JF, Rutherford LC, Keogh BF, Yacoub MH. Thromb Haemost; 2001 Feb 04; 85(2):195-7. PubMed ID: 11246531 [Abstract] [Full Text] [Related]
37. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update. Despotis GJ, Joist JH. J Cardiothorac Vasc Anesth; 1999 Aug 04; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245 [Abstract] [Full Text] [Related]
38. Practical approach to anticoagulation for cardiopulmonary bypass in the patient with congenital prolonged activated partial thromboplastin time. Cankovic L, Steenwyk BL, McGiffin DC, Nielsen VG. Blood Coagul Fibrinolysis; 2008 Oct 04; 19(7):725-6. PubMed ID: 18832918 [Abstract] [Full Text] [Related]
39. Activated clotting time monitoring of intraoperative heparinization: our experience and comparison of two techniques. Mabry CD, Thompson BW, Read RC, Campbell GS. Surgery; 1981 Nov 04; 90(5):889-95. PubMed ID: 7302842 [Abstract] [Full Text] [Related]